Study guide

7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals

Certified Wound Specialist Physician CWSP

Track your progress as you read

Finished sections get a check mark.

1 Introduction

About the CWSP Exam

2 Chapter 1: Integumentary Anatomy & Wound Healing Biology

1.1 Skin Anatomy, Microstructure & Epidermal-Dermal Barrier Function 1.2 Acute vs Chronic Wound Healing Phases & Cellular Kinetics 1.3 Extracellular Matrix Composition, Collagen Architecture & MMP Regulation

3 Chapter 2: Musculoskeletal & Neurologic Anatomy

2.1 Musculoskeletal Anatomy of the Leg & Foot 2.2 Neuroanatomy & Nerve Physiology for Wound Care

4 Chapter 3: Cell Signaling, Biofilm & Barriers to Healing

3.1 Growth Factors, Cytokines & Angiogenic Pathways 3.2 Biofilm Microbiology, Quorum Sensing & Phenotypic Resistance 3.3 Cellular Senescence, Hypoxia & Inflammatory Arrest 3.4 Metabolic, Steroid & Nutritional Impairments in Wound Healing

5 Chapter 4: Patient Evaluation & Vascular Diagnostics

4.1 Comprehensive Patient & Periwound Physical Examination 4.2 Noninvasive Macrovascular Hemodynamics: ABI, TBI & Segmental Pressures 4.3 Microvascular Perfusion Diagnostics: TcPO2, SPP & Near-Infrared Spectroscopy 4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts

6 Chapter 5: Pain, Risk, Functional & Nutrition Assessment

5.1 Wound Pain Assessment 5.2 Risk Assessment Tools & Risk Stratification 5.3 Functional & Cognitive Assessment 5.4 Nutrition Screening & Assessment

7 Chapter 6: Imaging, Biopsy, Atypical Wounds & Neuropathy

6.1 Musculoskeletal Imaging for Osteomyelitis & Deep Space Infections 6.2 Diagnostic Tissue Biopsy, Culture Techniques & Quantitative Microbiology 6.3 Diagnostic Differential of Atypical & Malignant Ulcerations 6.4 Comprehensive Diabetic Peripheral Neuropathy & Biomechanical Assessment

8 Chapter 7: Wound Bed Preparation, Debridement, Dressings & Topical Agents

7.1 TIME Principle & Wound Bed Preparation Framework 7.2 Surgical, Sharp, Enzymatic, Autolytic & Biosurgical Debridement Modalities 7.3 Advanced Wound Dressings, Exudate Control & Moisture Balance 7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals

9 Chapter 8: Cellular & Tissue-Based Products, NPWT & Hyperbaric Oxygen

8.1 Cellular, Acellular & Matrix-Like Advanced Biologics (CTPs) 8.2 Negative Pressure Wound Therapy (NPWT) & Instillation Protocols 8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety

10 Chapter 9: Biophysical Technologies: Electrical Stimulation & Ultrasound

9.1 Electrical Stimulation for Wound Healing 9.2 Therapeutic Ultrasound in Wound Care

11 Chapter 10: Revascularization, Antimicrobial Stewardship & Offloading

10.1 Revascularization for Limb Salvage 10.2 Systemic Antimicrobial Stewardship & Deep Infection Management 10.3 Mechanical Offloading, Pressure Redistribution & Total Contact Casting

12 Chapter 11: Surgical Closure & Healing Complications

11.1 Surgical Closure, Skin Grafts, Flaps & Amputation Levels 11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring

13 Chapter 12: Nutrition Therapy & Case Review

12.1 Nutrition Therapy for Wound Healing 12.2 Case Review: Synthesizing Data, Outliers & Prognosis

14 Chapter 13: Diabetic & Ischemic Lower-Extremity Wounds

13.1 Diabetic Foot Ulcers: Pathophysiology, Staging & Limb Salvage 13.2 Peripheral Arterial Disease & Ischemic Extremity Ulcerations 13.3 Mixed Arterial-Venous Disease & Complex Diagnostic Dilemmas

15 Chapter 14: Venous Disease, Pressure Injuries, Lymphedema & Edema

14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression 14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention 14.3 Lymphedema, Phlebolymphedema & Complete Decongestive Therapy 14.4 Edema: Systemic vs. Local Causes

16 Chapter 15: Inflammatory, Calcific, Medication-Induced & Dermatologic Wounds

15.1 Autoimmune & Inflammatory Ulcerations: Pyoderma Gangrenosum & Vasculitis 15.2 Calciphylaxis & Radiation Tissue Injury 15.3 Medication-Induced & Hematologic Atypical Wounds 15.4 Dermatologic Conditions That Cause or Complicate Wounds

17 Chapter 16: Traumatic Wounds, Burns & Frostbite

16.1 Traumatic Wounds: Lacerations, Bites, Degloving & Open Fractures 16.2 Thermal Burns & Frostbite

18 Chapter 17: Surgical, Infectious & Pediatric Wounds

17.1 Surgical Wounds, Surgical Site Infection & Dehiscence 17.2 Infectious Causes of Wounds: Necrotizing, Mycobacterial, Fungal & Other Infections 17.3 Pediatric Wound Care

19 Chapter 18: Reimbursement, Regulation & Documentation

18.1 CPT Coding, Modifiers & Documentation for Debridement and Biologics 18.2 Regulatory Compliance, CMS Quality Programs & Hospital-Acquired Conditions 18.3 Documentation, Legal Concepts & Confidentiality

20 Chapter 19: Ethics, Adherence, Epidemiology & Evidence-Based Practice

19.1 Clinical Ethics, Informed Consent & Palliative Wound Management 19.2 Patient Adherence & Psychosocial Care 19.3 Epidemiology of Chronic Wounds 19.4 Research Literacy, Evidence-Based Medicine & Quality Improvement

7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals

Key Takeaways Explain This Topic AI

Antiseptics (povidone-iodine, cadexomer iodine, chlorhexidine, hypochlorous acid and sodium hypochlorite, polyhexanide (PHMB), octenidine, silver, medical-grade honey, and acetic acid) act on many organisms at once and rarely select resistance, so they are preferred over topical antibiotics for bioburden control.

Topical antibiotics such as neomycin, bacitracin, and mupirocin should be used sparingly on chronic wounds because they promote resistance and commonly cause allergic contact dermatitis; neomycin and bacitracin are frequent allergens.

Use antiseptics for a defined period (for example, a 2-week trial) with a clear goal, then reassess; stop or switch when the wound improves or if it fails to respond.

Hydrogen peroxide should not be instilled under pressure or packed into closed cavities or sinus tracts because of the risk of gas embolism, and it offers little benefit in chronic wounds.

Becaplermin 0.01% gel (recombinant PDGF-BB) is FDA-approved for neuropathic diabetic foot ulcers that extend into subcutaneous tissue or beyond and have adequate blood supply, used with good wound care including offloading; its boxed cancer warning was removed in 2018.

Last updated: September 2026

7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals

Core Clinical Principle: Topical agents are prescriptions. Each needs an indication, a goal, a time limit, and a plan for reassessment. Antiseptics reduce bioburden without driving much resistance, topical antibiotics have narrow roles, and active topicals such as growth factors and enzymes work only in a well-prepared wound.

The CWSP outline lists topical agents in Patient Management, and managing wounds with dressings and topical agents and prescribing systemic or topical antimicrobial therapy are listed tasks. Dressings that carry antimicrobials (such as silver and iodine dressings) are covered with dressing selection; this section focuses on the agents themselves.

Wound Cleansing

Solutions: Normal saline or potable tap water is suitable for most wounds; trials and systematic reviews have not shown more infections with drinkable tap water. Use an antiseptic cleanser when bioburden or biofilm is suspected.

Irrigation pressure: About 4 to 15 psi removes debris without driving bacteria into tissue; a 35-mL syringe with a 19-gauge angiocatheter delivers about 8 psi.

Temperature: Warm solutions reduce pain and avoid cooling the wound bed.

Antiseptics

Agent Common Forms Strengths Cautions

Povidone-iodine 10% solution, ointment Broad spectrum, inexpensive; dries stable eschar Stings; avoid large-area or long-term use in thyroid disease, pregnancy, and infants

Cadexomer iodine 0.9% gel, paste, or pad Slow iodine release; absorbs exudate; evidence of biofilm activity Maximum amounts per application and course; avoid in iodine sensitivity, thyroid disease, pregnancy, and young children

Chlorhexidine 0.05% cleanser; 2–4% skin preparations Broad spectrum, residual activity Rare anaphylaxis; avoid contact with eyes, middle ear, and meninges; caution in premature infants

Sodium hypochlorite (Dakin's solution) 0.5% (full), 0.25% (half), 0.125% (quarter), and more dilute Broad spectrum, deodorizing, dissolves necrotic tissue Cytotoxic at higher strengths; protect periwound skin; short courses

Hypochlorous acid Dilute solutions and gels (commonly well below 0.1%) Broad activity with low tissue toxicity at use concentrations Short shelf life once opened for some products

Polyhexanide (PHMB) 0.1% solution or gel, often with betaine surfactant Low cytotoxicity, good for cleansing and soaks, biofilm disruption Rare allergy; avoid cartilage and central nervous system contact

Octenidine 0.05–0.1% solutions and gels Broad spectrum, low toxicity Tissue damage reported when injected under pressure into closed spaces

Silver Ionic silver, nanocrystalline silver, silver sulfadiazine Broad spectrum, many dressing forms Staining; rare argyria; use for defined periods

Medical-grade honey Leptospermum (manuka) gels and dressings Osmotic effect, low pH, hydrogen peroxide activity, methylglyoxal; supports autolysis Stinging; monitor glucose in large wounds; use sterilized medical-grade products only

Acetic acid 0.25–1% soaks (up to 5% in some protocols) Lowers pH; active against Pseudomonas aeruginosa Stings; cytotoxic at high strength

Hydrogen peroxide (3%) releases oxygen that foams away debris, but it is cytotoxic, adds little in chronic wounds, and should never be packed into or forcefully irrigated into deep cavities or sinus tracts , where released gas can cause gas embolism.

Antiseptic Stewardship

International consensus favors using an antiseptic for about 2 weeks as a trial when local infection or biofilm is suspected, alongside debridement, then reassessing: continue while signs improve, stop when they resolve, and change the plan if there is no improvement. In-vitro cytotoxicity does not always predict clinical harm, but the lowest effective concentration for the shortest useful time is a sound rule.

Topical Antibiotics

  • Agent Role Problems
  • Mupirocin Nasal MRSA decolonization; impetigo Resistance develops with prolonged use

Bacitracin, neomycin, polymyxin B Minor acute wounds Neomycin and bacitracin are common contact allergens, especially in patients with stasis dermatitis and leg ulcers

  • Metronidazole gel (0.75–1%) Odor from anaerobes in malignant and palliative wounds Limited role in healing
  • Silver sulfadiazine Burns Delays epithelialization; avoid in late pregnancy and newborns
  • Gentamicin cream Rarely justified Promotes resistance to an important systemic drug

Guidelines such as those from the IWGDF advise against using topical antimicrobials to try to speed healing of uninfected diabetic foot ulcers, and systemic antibiotics, not topical ones, treat spreading infection.

Active Topicals and Skin Protectants

Becaplermin 0.01% gel: Recombinant human platelet-derived growth factor-BB for lower-extremity neuropathic diabetic ulcers that extend into subcutaneous tissue or beyond with adequate blood supply, applied daily with debridement and offloading. It should not be used on wounds with neoplasm at the site. The boxed warning about cancer mortality was removed in 2018.

Collagenase (250 units/g ointment): Enzymatic debridement; keep away from agents that inactivate it (such as silver and iodine products and detergents).

Topical timolol: Beta-blocker used off-label for chronic wounds and pyogenic granuloma; small studies suggest faster epithelialization.

Topical corticosteroids: Potent steroids (such as clobetasol) for pyoderma gangrenosum edges, hypergranulation, and periwound dermatitis; tacrolimus is a steroid-sparing option.

Silver nitrate sticks: Chemical cautery for hypergranulation and pinpoint bleeding; causes pain and black staining.

Skin protectants: Zinc oxide, dimethicone, and petrolatum creams and ointments, and no-sting liquid barrier films (terpolymer or cyanoacrylate), protect periwound skin from exudate, adhesives, and incontinence.

Topical oxygen: Devices that deliver oxygen to the wound surface have some supportive trials, but Medicare's hyperbaric oxygen national coverage determination states that topical oxygen application is not covered.

  • Clinical Traps
  • Trap 1: Endless Silver or Iodine

Months of antimicrobial dressings on a wound that is not improving delay the real answer: debridement, offloading, revascularization, biopsy, or a systemic infection workup.

Trap 2: Spreading Dermatitis Blamed on Infection

An itchy, weeping, sharply shaped rash that spreads beyond the area where an ointment was applied suggests allergic contact dermatitis. Stop the agent rather than adding antibiotics.